Product Description
Similar to a vitamin D3 preparation.
Mechanisms of Action: D3 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Maruho
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Psoriasis|Palmoplantar Psoriasis|Keratoderma, Palmoplantar
Phase 2: Leukemia|Psoriasis
Phase 1: Psoriasis|Healthy Volunteers
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02256930 |
M518101-US07 | P1 |
Completed |
Healthy Volunteers |
2014-11-01 |
2019-03-20 |
Treatments |
|
NCT02227069 |
M518101-US06 | P1 |
Completed |
Healthy Volunteers |
2014-10-01 |
2019-03-20 |
Treatments |
|
NCT01844973 |
M518101-US05 | P1 |
Completed |
Psoriasis |
2013-08-01 |
2019-03-19 |
Treatments |
|
NCT02970331 |
CLS008-CO-PR-001 | P2 |
Withdrawn |
Psoriasis |
2019-12-01 |
39% |
2021-01-06 |
Primary Endpoints|Treatments|Trial Status |
JapicCTI-183940 |
JapicCTI-183940 | P2 |
Unknown |
Unknown |
2019-06-30 |
|||
JapicCTI-132137 |
JapicCTI-132137 | P2 |
Completed |
Psoriasis |
2015-03-01 |
|||
JapicCTI-111473 |
JapicCTI-111473 | P2 |
Completed |
Psoriasis |
2012-04-01 |
|||
JapicCTI-111472 |
JapicCTI-111472 | P2 |
Completed |
Psoriasis |
2012-04-01 |
|||
NCT01301157 |
M518101-US01 | P2 |
Completed |
Psoriasis |
2012-01-01 |
2019-03-19 |
Treatments |
|
2009-010805-35 |
2009-010805-35 | P2 |
Completed |
Psoriasis |
2010-03-08 |
2022-03-13 |
Treatments |
|
ACTRN12619001655134p |
2006-7041-83/hah | P2 |
Not yet recruiting |
Leukemia |
None |
|||
NCT00884169 |
M518101-EU03 | P2 |
Completed |
Psoriasis |
None |
2019-03-18 |
Treatments |
|
JapicCTI-152947 |
JapicCTI-152947 | P3 |
Completed |
Palmoplantar Psoriasis|Keratoderma, Palmoplantar |
2017-03-01 |
|||
JapicCTI-152946 |
JapicCTI-152946 | P3 |
Completed |
Psoriasis |
2016-09-01 |
|||
NCT01908595 |
M518101-US04 | P3 |
Completed |
Psoriasis |
2015-05-01 |
2019-03-19 |
Treatments |
|
NCT01878461 |
M518101-US03 | P3 |
Completed |
Psoriasis |
2015-05-01 |
2019-03-19 |
Treatments |
|
NCT01873677 |
M518101-US02 | P3 |
Completed |
Psoriasis |
2015-04-01 |
2019-03-19 |
Treatments |
|
2013-001632-21 |
2013-001632-21 | P3 |
Completed |
Psoriasis |
2015-01-07 |
2022-03-13 |
Treatments |
|
NCT01989429 |
M518101-EU04 | P3 |
Completed |
Psoriasis |
2014-12-01 |
2025-02-07 |
Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|